Improving Lifestyles and Growing Preference for Minimally Invasive Surgeries Are Expected to Drive the Demand for Facial Injectables Across the U.S.
The North America facial injectables market is quite monopolistic in nature with one player dominating the overall market dynamics. As of 2016, Allergan Plc., held a share 62.0% in the regional market. The company dominance is a result of the strong brand value of its drugs like Botox & Juvederm. Presently, Botox is leading the market and is expected to retain its stance all throughout 2024.
View full press release